| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |